透析老年患者潜在不适当药物减停相关因素的利益相关者视角
共访谈76名参与者(53名临床医生和23名患者),识别出四个主题:系统层面障碍、共同管理不明确、知识有限以及患者优先控制症状。结论指出整合减停面临健康系统孤岛、时间限制、共同管理行为和知识态度等挑战。
要点
- 系统层面障碍包括电子病历互操作性有限、时间限制和竞争性优先事项。
- 临床医生对处方者边界谨慎,角色划分不清,共同管理未定义。
- 患者优先控制症状而非潜在危害,临床医生预期患者会抵制减停。
核心结论
- 将减停整合到透析诊所的挑战包括健康系统孤岛、时间限制、共同管理行为以及临床医生和患者对减停的知识和态度。
主要发现
- 共访谈76名参与者:53名临床医生(8个焦点小组和11个访谈)和23名患者。
- 临床医生中,24名在透析诊所工作,18名在初级保健工作,11名是药剂师。
- 患者中,13名(56%)年龄65岁及以上,14名(61%)为黑种人,16名(70%)报告至少服用一种潜在不适当药物。
- 识别出四个主题:系统层面障碍、临床医生之间共同管理未定义、对潜在不适当药物的知识有限、患者优先控制症状而非潜在危害。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Potentially inappropriate medications, or medications that generally carry more risk of harm than benefit in older adults, are commonly prescribed to older adults receiving dialysis. Deprescribing, a systematic approach to reducing or stopping a medication, is a potential solution to limit potentially inappropriate medications use. Our objective was to identify clinicians and patient perspectives on factors related to deprescribing to inform design of a deprescribing program for dialysis clinics. METHODS: We conducted rapid qualitative analysis of semistructured interviews and focus groups with clinicians (dialysis clinicians, primary care providers, and pharmacists) and patients (adults receiving hemodialysis aged 65 years or older and those aged 55-64 years who were prefrail or frail) from March 2019 to December 2020. RESULTS: We interviewed 76 participants (53 clinicians [eight focus groups and 11 interviews] and 23 patients). Among clinicians, 24 worked in dialysis clinics, 18 worked in primary care, and 11 were pharmacists. Among patients, 13 (56%) were aged 65 years or older, 14 (61%) were Black race, and 16 (70%) reported taking at least one potentially inappropriate medication. We identified four themes (and corresponding subthemes) of contextual factors related to deprescribing potentially inappropriate medications: ( 1 ) system-level barriers to deprescribing (limited electronic medical record interoperability, time constraints and competing priorities), ( 2 ) undefined comanagement among clinicians (unclear role delineation, clinician caution about prescriber boundaries), ( 3 ) limited knowledge about potentially inappropriate medications (knowledge limitations among clinicians and patients), and ( 4 ) patients prioritize symptom control over potential harm (clinicians expect resistance to deprescribing, patient weigh risks and benefits). CONCLUSIONS: Challenges to integration of deprescribing into dialysis clinics included siloed health systems, time constraints, comanagement behaviors, and clinician and patient knowledge and attitudes toward deprescribing.
引用
- Hall RK, Rutledge J, Lucas A, et al. Stakeholder Perspectives on Factors Related to Deprescribing Potentially Inappropriate Medications in Older Adults Receiving Dialysis. Clin J Am Soc Nephrol. 2023. PMID: 37499693. doi:10.2215/CJN.0000000000000229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。